Article Archive

Dell dropped 7.27% on July 2 as AI-linked stocks retreated broadly on fears that chip demand may be cooling, erasing gains from a 300% run.

Lumentum dropped 9.09% on July 2 alongside Coherent and Applied Optoelectronics in a broad photonics sector reset. Here is what happened.

Rivian delivered 12,194 vehicles in Q2 2026, beating Wall Street's ~10,500 estimate by 16%, and raised its full-year outlook to 65,000–70,000 units — RIVN surged 8.44% on July 2.

Jim Chanos called IREN's 18.2 million RSU package a 'corporate payout machine' — shares fell 10.39% on July 2 as governance scrutiny hit the bitcoin miner days after its Russell 1000 inclusion.

Jim Cramer called Intel his favorite stock on Mad Money, crediting CEO Lip-Bu Tan's turnaround and naming three major growth opportunities for INTC.

Lucid named Alexander De Bock as CFO while posting Q2 production of 4,774 vehicles and deliveries of 3,953, as LCID fell 8.30% on July 2.

Coherent secured a master development and supply agreement with AXT-Tongmei, including a $22.29M prepayment to expand Beijing wafer capacity through 2028.

A federal lawsuit filed June 25 accuses Micron, Samsung, and SK Hynix of secretly restricting memory chip supply. MU fell 5.49% on July 2.

Accenture lands NiCE's inaugural AI Specialization partner status, expanding its enterprise AI push alongside ServiceNow work and the Accenture Edge business.

The FDA expanded CASGEVY's label to patients ages 2 and older with sickle cell disease or beta thalassemia, marking the first gene therapy cleared for young children with SCD.

West Pharmaceutical closed the sale of SmartDose 3.5mL on-body delivery system rights on July 1, shedding a manufacturing unit in a planned divestiture.

Guggenheim's John DiFucci upgraded NOW to Buy, arguing AI-disruption fears pushed SaaS valuations too low

Meta is building a cloud business to sell surplus AI compute capacity, a move that sent shares up 8.81% on July 1 and rattled rival CoreWeave by 15%.

Wedbush started Kratos Defense at Outperform with an $85 price target, framing the company as a misunderstood supplier to the entire U.S. defense complex.

Robinhood expanded into European derivatives and UK crypto while setting a Guinness AI record, sending HOOD up 8.35% on July 1.

A $400M uncommitted facility from JPMorgan gives Hims & Hers new financial flexibility as it scales healthcare and pharmacy operations.

The crypto industry has donated $189M ahead of the 2026 midterms, with Coinbase, Ripple, and Gemini leading the charge to shape U.S. policy.

ASML lifted its revenue outlook, citing stronger-than-expected AI infrastructure spending. Here is what the guidance raise means for the EUV leader.

AMD's Versal Premium Gen 2 brings memory-in-package technology to high-bandwidth AI, networking, and aerospace workloads, extending beyond CPUs and GPUs.

General Mills posted Q4 non-GAAP EPS of $0.95, beating consensus by 18.2%, with sales of $4.61B up 1.2% YoY. Here is what the numbers show.

Zimmer Biomet is paying $140M to acquire the iovera° device from Pacira, with milestone payments stretching through December 2031.

ON Semiconductor's $7B all-stock bid for Synaptics is the chipmaker's biggest deal ever, reshaping its product portfolio and balance sheet in one move.

Digital Realty just paid $3.5B for Blackstone's Northern Virginia hyperscale data centers, a fully leased portfolio that reshapes its AI infrastructure footprint.

Alexandria spotlights its Megacampus strategy in its 2025 Corporate Responsibility Report, linking life science innovation clusters to long-term shareholder value creation.

Wedbush called AVAV a long-term winner in defense tech on July 1, citing its distinct position in the evolving unmanned systems ecosystem.

ICE issued a $220M contract solicitation experts say only Axon can win, two weeks after a Trump family account disclosed buying up to $5M in AXON stock.

APD dropped its Louisiana clean-energy project and booked a charge of up to $2.9B, yet investors sent the stock up 8.04% as the exit signals a strategic reset.

ZORYVE cream 0.3% becomes the first once-daily, non-steroidal therapy cleared for plaque psoriasis in children as young as 2, expanding Arcutis' label.

B of A cut AMPH to Underperform and trimmed its price target from $25 to $20: the reasoning behind the call matters for holders.

Alphabet took Verizon's slot in the 30-stock Dow on June 30, ending VZ's tenure in the index. VZ fell 5.24% on June 29.

Honeywell split into two public companies Monday, with HONA debuting on Nasdaq and HON falling 50.95% as the aerospace business trades separately.

Taiwanese authorities raided SMCI's offices over alleged Nvidia chip smuggling to China, sending shares down 8.10% on June 29, 2026.

SpaceX is joining both the Russell indexes and the Nasdaq 100 by July 7, forcing mandatory buying from passive funds benchmarked to each index at a $2.16T market cap.

eBay turned away GameStop's acquisition approach, but Ryan Cohen reaffirmed the pursuit and lifted GameStop's fiscal 2026 adjusted EBITDA outlook to above $600 million.

Tesla launched FSD v14 Lite to millions of older vehicles and began Cybercab tests in Austin without a steering wheel or pedals, two concrete product milestones on the same day.

Strategy announced a sweeping capital overhaul including a Bitcoin monetization program and up to $1.25B in potential BTC sales, reshaping how the company funds operations.

Biogen just bought RayThera for up to $1B and secured an FDA Breakthrough Therapy designation for Salanersen, stacking two immunology pipeline wins in one session.

FactSet's new Portfolio Analytics MCP connects audit-approved portfolio data to conversational AI tools, including private LLMs, as FDS gained 10.97% on June 26.

BofA raised AMAT's target to $720 from $540 and Wells Fargo lifted it to $740 from $715, as Applied Materials exits Russell Value indexes for the Russell Top 50.

Rocket Lab agreed to buy Iridium for $54 per share in a cash-and-stock deal, combining launch capability with a global satellite communications network.

Reuters reported Qualcomm is set to acquire AI startup Modular for nearly $4 billion in stock, adding software that lets AI models run across different hardware platforms.

SLB unveiled a new AI Digital Marketplace platform while CEO Olivier Le Peuch detailed the NVIDIA partnership on CNBC, and Stifel raised its price target to $64.

Barclays lifted its HIMS target from $29 to $39, citing GLP-1 momentum and a July FDA peptide ruling that analysts say could be the next major catalyst.

Amazon's push to sell Trainium chips beyond its own cloud makes Marvell, the lead design partner, a direct commercial beneficiary of that platform's expansion.

Kroger posted Q1 EPS of $1.58 vs. the $1.64 consensus, as deliberate price cuts and higher transport costs pressured profit even as eCommerce surged 19%.

ACN posted EPS of $3.80 vs. the $3.75 estimate, but a corporate spending pullback sent shares down 17.97% on June 18, 2026.

Jazz Pharmaceuticals is paying AbCellera $56M upfront, with up to $792M more per program, to co-develop next-gen cancer-fighting antibodies.

Phase 3 data for Intellia's lonvo-z showed an 87% cut in HAE attacks, reinforcing the regulatory outlook for its one-time CRISPR gene editing therapy.

Gossamer Bio swapped $181M of 2027 convertible notes into new secured debt and equity, leaving $18.95M of old notes outstanding and issuing 317.6M shares.

UBS analyst Kevin Mcveigh lifted his EFX target to $215 from $212, keeping a Buy rating on a day Equifax shares fell 7.35% to close at $154.84.

Final Phase 3 CLL14 trial results on a fixed-duration venetoclax combo were presented in Stockholm, adding clinical depth to AbbVie's hematology franchise.

Adjusted EPS of $0.36 beat the $0.23 consensus by 56.5%, while $178.4M in sales topped the $155.3M estimate by nearly 15% , SWBI also raised its dividend.

CoreWeave's Nasdaq-100 addition is forcing index-tracking fund purchases, with shares gaining 9.67% on Tuesday backed by a $99.4B contracted backlog.

Up to $50M in CHIPS Act funding will double Coherent's Sherman, Texas facility and quadruple wafer capacity, targeting AI datacenter optical networking demand.

FDA releases positive briefing documents ahead of a June 18 VRBPAC meeting on Moderna's mFlusiva, as the company also plans three vaccine launches over two years.

CarMax beat Q1 EPS by 39% and topped $8B in revenue, its third consecutive quarter of double-digit EPS surprises. Here is what drove the results.